Advisor Group Holdings, Inc. Bicycle Therapeutics PLC Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,042 shares of BCYC stock, worth $13,525. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,042

Previous 1,259 17.24%

Holding current value

$13,525

Previous $25,000 8.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$19.58 - $27.24 $4,248 - $5,911	-217 Reduced 17.24%	1,042 $23,000
Q2 2024 Aug 13, 2024	SELL	$20.02 - $24.69 $2,602 - $3,209	-130 Reduced 9.36%	1,259 $25,000
Q1 2024 May 10, 2024	SELL	$16.75 - $26.1 $9,949 - $15,503	-594 Reduced 29.95%	1,389 $34,000
Q4 2023 Feb 12, 2024	SELL	$13.29 - $22.2 $18,140 - $30,303	-1,365 Reduced 40.77%	1,983 $35,000
Q3 2023 Nov 13, 2023	BUY	$19.9 - $26.25 $20,457 - $26,985	1,028 Added 44.31%	3,348 $67,000
Q2 2023 Aug 10, 2023	BUY	$18.95 - $28.67 $23,877 - $36,124	1,260 Added 118.87%	2,320 $59,000
Q1 2023 May 12, 2023	SELL	$20.02 - $31.37 $5,005 - $7,842	-250 Reduced 19.08%	1,060 $22,000
Q4 2022 Feb 10, 2023	SELL	$20.37 - $32.9 $2,037 - $3,290	-100 Reduced 7.09%	1,310 $38,000
Q3 2022 Nov 14, 2022	BUY	$17.49 - $28.44 $8,045 - $13,082	460 Added 48.42%	1,410 $33,000
Q2 2022 Aug 10, 2022	SELL	$12.95 - $46.99 $40,002 - $145,152	-3,089 Reduced 76.48%	950 $16,000
Q1 2022 May 04, 2022	SELL	$40.12 - $59.5 $41,123 - $60,987	-1,025 Reduced 20.24%	4,039 $176,000
Q3 2021 Nov 05, 2021	SELL	$27.95 - $44.24 $367,039 - $580,959	-13,132 Reduced 72.17%	5,064 $210,000
Q2 2021 Aug 02, 2021	BUY	$27.0 - $32.28 $69,363 - $82,927	2,569 Added 16.44%	18,196 $552,000
Q1 2021 May 13, 2021	SELL	$19.12 - $30.25 $123,993 - $196,171	-6,485 Reduced 29.33%	15,627 $467,000
Q4 2020 Feb 10, 2021	SELL	$17.95 - $21.36 $71,584 - $85,183	-3,988 Reduced 15.28%	22,112 $397,000
Q3 2020 Nov 12, 2020	SELL	$15.3 - $20.8 $122,400 - $166,400	-8,000 Reduced 23.46%	26,100 $497,000
Q2 2020 Aug 14, 2020	BUY	$12.63 - $18.21 $429,420 - $619,140	34,000 Added 34000.0%	34,100 $537,000
Q1 2020 May 18, 2020	BUY	$9.82 - $18.0 $982 - $1,800	100 New	100 $1,000

Others Institutions Holding BCYC

# of Institutions

113

Shares Held

40.8M

Call Options Held

39.6K

Put Options Held

24.6K

View Full List

About BICYCLE THERAPEUTICS plc

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $385M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

More about BCYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Bicycle Therapeutics PLC Transaction History